Cullinan Therapeutics
CGEM
#6903
Rank
NZ$0.77 B
Marketcap
$13.24
Share price
-1.07%
Change (1 day)
-52.16%
Change (1 year)

EPS for Cullinan Therapeutics (CGEM)

EPS in 2024 (TTM): -$6.58

According to Cullinan Therapeutics's latest financial reports the company's current EPS (TTM) is -$7.16. In 2022 the company made an earnings per share (EPS) of $4.47 an increase over its 2021 EPS that were of -$2.68.

EPS history for Cullinan Therapeutics from 2021 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-$6.58
2022$4.47-266.48%
2021-$2.68